- UArizona Cancer Center researchers develop new way to target cancer cells
- Novartis shareholders approve the proposed 100% Spin-off of Sandoz
- Cancer drug conquers covid inflammation
- A suit of armor for cancer-fighting cells
- Vividion Therapeutics starts Phase I clinical trial in advanced solid tumors with KEAP1 activator
- Preventing the tissue's response to stiffness may be key to slowing the progression of breast tumors
- GSK and Save the Children renew award-winning partnership, with focus on 'zero dose' children who have never received a vaccine
- A protein on cancer cells supports the immune response against tumors
- Turmeric may be as good for treating indigestion as drug to curb excess stomach acid
- FDA takes action on updated mRNA COVID-19 vaccines to better protect against currently circulating variants
- Antidepressant use in people with both physical health problems and depression
- A free online tool can help prostate cancer patients save on out-of-pocket drug costs
- Roche's Alecensa delivers unprecedented Phase III results for people with ALK-positive early-stage lung cancer
- First-in-class targeted microRNA therapy slows cancer tumor growth
- Why breast cancer survivors don't take their medication, and what can be done
- Statins linked to lower risk of colorectal cancer in patients with ulcerative colitis
- How Unique Immune Cells can Recognize - and destroy - Tumors
- BlueRock's Phase I study with bemdaneprocel in patients with Parkinson's disease meets primary endpoint
- Drug that targets scar-like tissue in tumours shows promise for aggressive pancreatic cancer
- Novartis completes acquisition of Chinook Therapeutics
Website: https://www.worldpharmanews.com/
